086710 — Sunjin Beauty Science Co Balance Sheet
0.000.00%
- KR₩111bn
- KR₩172bn
- KR₩79bn
Annual balance sheet for Sunjin Beauty Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11,922 | 13,801 | 11,499 | 9,515 | 11,081 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11,488 | 11,160 | 31,582 | 13,599 | 14,032 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 33,797 | 36,080 | 56,803 | 39,839 | 46,629 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 55,425 | 63,116 | 74,942 | 81,208 | 101,709 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 93,165 | 107,618 | 135,571 | 125,772 | 154,084 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25,291 | 16,678 | 32,591 | 26,924 | 40,574 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 62,205 | 61,156 | 71,007 | 55,910 | 75,189 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 30,960 | 46,461 | 64,564 | 69,862 | 78,896 |
| Total Liabilities & Shareholders' Equity | 93,165 | 107,618 | 135,571 | 125,772 | 154,084 |
| Total Common Shares Outstanding |